Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-08-23

FDA Approved: KORSUVA — Original Application (Vifor (International), Inc.)

View source ↗

Summary

FDA approved Korsuva (difelikefalin) for the treatment of moderate-to-severe pruritus in adults with chronic kidney disease on hemodialysis, based on pivotal cl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KORSUVA (Difelikefalin)

Snippet

ORIG AP for KORSUVA (DIFELIKEFALIN)